Neuropsychological assessment of hepatic encephalopathy: ISHEN practice guidelines

Liver International

Volumn 29, Issue 5, 2009, Pages 629-635

  Randolph, Christopher ^a,k   Hilsabeck, Robin ^b   Kato, Ainobu ^c   Kharbanda, Parampreet ^d   Li, Yu Yuan ^e   Mapelli, Daniela ^f   Ravdin, Lisa D ^g   Romero Gomez, Manuel ^h   Stracciari, Andrea ⁱ   Weissenborn, Karin ^j  

^a LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c IWATE MEDICAL UNIVERSITY   (Japan)

^d POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

^e GUANGZHOU FIRST PEOPLE'S HOSPITAL   (China)

^f UNIVERSITY OF PADOVA   (Italy)

^g WEILL CORNELL MEDICAL CENTER   (United States)

^h HOSPITAL UNIVERSITARIO DE VALME   (Spain)

ⁱ UNIVERSITY OF BOLOGNA   (Italy)

^j HANNOVER MEDICAL SCHOOL   (Germany)

^k NONE   (United States)

more..

Author keywords

Assessment; Encephalopathy; Hepatic; Neuropsychological; Outcome; Psychometric

Indexed keywords

CLINICAL TRIAL; COGNITIVE DEFECT; EARLY DIAGNOSIS; EVIDENCE BASED MEDICINE; HEPATIC ENCEPHALOPATHY; HIGH RISK PATIENT; HUMAN; NEUROIMAGING; NEUROPSYCHOLOGICAL TEST; PRACTICE GUIDELINE; PROGNOSIS; PSE SYNDROM TEST; PSYCHOMETRY; QUALITY OF LIFE; RATING SCALE; REPEATABLE BATTERY FOR THE ASSESSMENT OF NEUROPSYCHOLOGICAL STATUS; REVIEW; VALIDATION PROCESS;

COGNITION DISORDERS; HEPATIC ENCEPHALOPATHY; HUMANS; NEUROPSYCHOLOGICAL TESTS; SEVERITY OF ILLNESS INDEX;

EID: 64749100701     PISSN: 14783223     EISSN: 14783231     Source Type: Journal    
DOI: 10.1111/j.1478-3231.2009.02009.x     Document Type: Review

References (70)

1. Li YY, Nie YQ, Sha WH, et al. Prevalence of subclinical hepatic encephalopathy in cirrhotic patients in China. World J Gastroenterol 2004; 10: 2397-401.
2. Poordad FF. Review article: The burden of hepatic encephalopathy. Aliment Pharmacol Ther 2007; 25 (Suppl. 1): 3-9.
3. Wein C, Koch H, Popp B, Oehler G, Schauder P. Minimal hepatic encephalopathy impairs fitness to drive. Hepatology 2004; 39: 739-45.
4. Groeneweg M, Quero JC, De Bruijn I, et al. Subclinical hepatic encephalopathy impairs daily functioning. Hepatology 1998; 28: 45-9.
5. Bustamante J, Rimola A, Ventura PJ, et al. Prognostic significance of hepatic encephalopathy in patients with cirrhosis. J Hepatol 1999; 30: 890-5.
6. Conn HO, Leevy CM, Vlahcevic ZR, et al. Comparison of lactulose and neomycin in the treatment of chronic portal-systemic encephalopathy. A double blind controlled trial. Gastroenterology 1977; 72 (Part 1): 573-83.
7. Ferenci P, Lockwood A, Mullen K, et al. Hepatic encephalopathy - definition, nomenclature, diagnosis, and quantification: Final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998. Hepatology 2002; 35: 716-21.
8. Amodio P, Montagnese S, Gatta A, Morgan MY. Characteristics of minimal hepatic encephalopathy. Metab Brain Dis 2004; 19: 253-67.
9. Marchesini G, Bianchi G, Amodio P, et al. Factors associated with poor health-related quality of life of patients with cirrhosis. Gastroenterology 2001; 120: 170-8.
10. Schomerus H, Hamster W. Quality of life in cirrhotics with minimal hepatic encephalopathy. Metab Brain Dis 2001; 16: 37-41.
11. Watanabe A, Tuchida T, Yata Y, Kuwabara Y. Evaluation of neuropsychological function in patients with liver cirrhosis with special reference to their driving ability. Metab Brain Dis 1995; 10: 239-48.
12. Das A, Dhiman RK, Saraswat VA, Verma M, Naik SR. Prevalence and natural history of subclinical hepatic encephalopathy in cirrhosis. J Gastroenterol Hepatol 2001; 16: 531-5.
13. Romero-Gomez M, Boza F, Garcia-Valdecasas MS, Garcia E, Aguilar-Reina J. Subclinical hepatic encephalopathy predicts the development of overt hepatic encephalopathy. Am J Gastroenterol 2001; 96: 2718-23.
14. Romero-Gomez M, Grande L, Camacho I, et al. Altered response to oral glutamine challenge as prognostic factor for overt episodes in patients with minimal hepatic encephalopathy. J Hepatol 2002; 37: 781-7.
15. Saxena N, Bhatia M, Joshi YK, et al. Electrophysiological and neuropsychological tests for the diagnosis of subclinical hepatic encephalopathy and prediction of overt encephalopathy. Liver 2002; 22: 190-7.
16. Tarter RE, Switala J, Plail J, Havrilla J, Van Thiel DH. Severity of hepatic encephalopathy before liver transplantation is associated with quality of life after transplantation. Arch Intern Med 1992; 152: 2097-101.
17. Prasad S, Dhiman RK, Duseja A, et al. Lactulose improves cognitive functions and health-related quality of life in patients with cirrhosis who have minimal hepatic encephalopathy. Hepatology 2007; 45: 549-59.
18. Amodio P, Gatta A. Neurophysiological investigation of hepatic encephalopathy. Metab Brain Dis 2005; 20: 369-79.
19. Amodio P, Valenti P, Del Piccolo F, et al. P300 latency for the diagnosis of minimal hepatic encephalopathy: Evidence that spectral EEG analysis and psychometric tests are enough. Dig Liver Dis 2005; 37: 861-8.
20. Zeneroli ML, Pinelli G, Gollini G, et al. Visual evoked potential: A diagnostic tool for the assessment of hepatic encephalopathy. Gut 1984; 25: 291-9.
21. Yang SS, Chu NS, Liaw YF. Somatosensory evoked potentials in hepatic encephalopathy. Gastroenterology 1985; 89: 625-30.
22. Sandford NL, Saul RE. Assessment of hepatic encephalopathy with visual evoked potentials compared with conventional methods. Hepatology 1988; 8: 1094-8.
23. Sharma P, Sharma BC, Puri V, Sarin SK. Critical flicker frequency: diagnostic tool for minimal hepatic encephalopathy. J Hepatol 2007; 47: 67-73.
24. Romero-Gomez M, Cordoba J, Jover R, et al. Value of the critical flicker frequency in patients with minimal hepatic encephalopathy. Hepatology 2007; 45: 879-85.
25. Kircheis G, Wettstein M, Timmermann L, Schnitzler A, Haussinger D. Critical flicker frequency for quantification of low-grade hepatic encephalopathy. Hepatology 2002; 35: 357-66.
26. Zeneroli ML, Cioni G, Crisi G, Vezzelli C, Ventura E. Globus pallidus alterations and brain atrophy in liver cirrhosis patients with encephalopathy: An MR imaging study. Magn Reson Imaging 1991; 9: 295-302.
27. Kulisevsky J, Pujol J, Deus J, Balanzo J, Pujol A. Magnetic resonance imaging pallidal hypersignal in cirrhotic subjects. Hepatology 1996; 24: 282-3.
28. Inoue E, Hori S, Narumi Y, et al. Portal-systemic encephalopathy: presence of basal ganglia lesions with high signal intensity on MR images. Radiology 1991; 179: 551-5.
29. Taylor-Robinson SD, Oatridge A, Hajnal JV, et al. MR imaging of the basal ganglia in chronic liver disease: Correlation of T1-weighted and magnetisation transfer contrast measurements with liver dysfunction and neuropsychiatric status. Metab Brain Dis 1995; 10: 175-88.
30. Miese F, Kircheis G, Wittsack HJ, et al. 1H-MR spectroscopy, magnetization transfer, and diffusion-weighted imaging in alcoholic and nonalcoholic patients with cirrhosis with hepatic encephalopathy. Am J Neuroradiol 2006; 27: 1019-26.
31. Weissenborn K, Bokemeyer M, Ahl B, et al. Functional imaging of the brain in patients with liver cirrhosis. Metab Brain Dis 2004; 19: 269-80.
32. Weissenborn K, Ennen JC, Schomerus H, Ruckert N, Hecker H. Neuropsychological characterization of hepatic encephalopathy. J Hepatol 2001; 34: 768-73.
33. McCrea M, Cordoba J, Vessey G, Blei AT, Randolph C. Neuropsychological characterization and detection of subclinical hepatic encephalopathy. Arch Neurol 1996; 53: 758-63.
34. Bahceci F, Yildirim B, Karincaoglu M, Dogan I, Sipahi B. Memory impairment in patients with cirrhosis. J Natl Med Assoc 2005; 97: 213-6.
35. Tarter RE, Arria AM, Carra J, Van Thiel DH. Memory impairments concomitant with nonalcoholic cirrhosis. Int J Neurosci 1987; 32: 853-9.
36. Meyer T, Eshelman A, Abouljoud M. Neuropsychological changes in a large sample of liver transplant candidates. Transplant Proc 2006; 38: 3559-60.
37. Gitlin N, Lewis DC, Hinkley L. The diagnosis and prevalence of subclinical hepatic encephalopathy in apparently healthy, ambulant, non-shunted patients with cirrhosis. J Hepatol 1986; 3: 75-82.
38. Sorrell JH, Zolnikov BJ, Sharma A, Jinnai I. Cognitive impairment in people diagnosed with end-stage liver disease evaluated for liver transplantation. Psychiatry Clin Neurosci 2006; 60: 174-81.
39. Weissenborn K, Heidenreich S, Giewekemeyer K, Ruckert N, Hecker H. Memory function in early hepatic encephalopathy. J Hepatol 2003; 39: 320-5.
40. Weissenborn K, Giewekemeyer K, Heidenreich S, et al. Attention, memory, and cognitive function in hepatic encephalopathy. Metab Brain Dis 2005; 20: 359-67.
41. Tarter RE, Hegedus AM, Van Thiel DH, Edwards N, Schade RR. Neurobehavioral correlates of cholestatic and hepatocellular disease: differentiation according to disease specific characteristics and severity of the identified cerebral dysfunction. Int J Neurosci 1987; 32: 901-10.
42. Sood GK, Sarin SK, Mahaptra J, Broor SL. Comparative efficacy of psychometric tests in detection of subclinical hepatic encephalopathy in nonalcoholic cirrhotics: Search for a rational approach. Am J Gastroenterol 1989; 84: 156-9.
43. Tarter RE, Hegedus AM, Van Thiel DH, et al. Nonalcoholic cirrhosis associated with neuropsychological dysfunction in the absence of overt evidence of hepatic encephalopathy. Gastroenterology 1984; 86: 1421-7.
44. Zeegen R, Drinkwater JE, Dawson AM. Method for measuring cerebral dysfunction in patients with liver disease. Br Med J 1970; 2: 633-6.
45. Shawcross DL, Wright G, Olde Damink SW, Jalan R. Role of ammonia and inflammation in minimal hepatic encephalopathy. Metab Brain Dis 2007; 22: 125-38.
46. Quero JC, Hartmann IJ, Meulstee J, Hop WC, Schalm SW. The diagnosis of subclinical hepatic encephalopathy in patients with cirrhosis using neuropsychological tests and automated electroencephalogram analysis. Hepatology 1996; 24: 556-60.
47. Tarter RE, Van Thiel DH, Arria AM, Carra J, Moss H. Impact of cirrhosis on the neuropsychological test performance of alcoholics. Alcohol Clin Exp Res 1988; 12: 619-21.
48. Binesh N, Huda A, Thomas MA, et al. Hepatic encephalopathy: A neurochemical, neuroanatomical, and neuropsychological study. J Appl Clin Med Phys 2006; 7: 86-96.
49. Mattarozzi K, Stracciari A, Vignatelli L, et al. Minimal hepatic encephalopathy: Longitudinal effects of liver transplantation. Arch Neurol 2004; 61: 242-7.
50. Della Sala S, Lunghi A, Marini A, Nespoli A, Spinnler H. Neuropsychological evaluation of bleeding cirrhotic patients. Schweiz Arch Neurol Psychiatr 1992; 143: 355-69.
51. Bajaj JS, Saeian K, Verber MD, et al. Inhibitory control test is a simple method to diagnose minimal hepatic encephalopathy and predict development of overt hepatic encephalopathy. Am J Gastroenterol 2007; 102: 754-60.
52. Malaguarnera M, Greco F, Barone G, Gargante MP, Toscano MA. Bifidobacterium longum with fructo-oligosaccharide (FOS) treatment in minimal hepatic encephalopathy: A randomized, double-blind, placebo-controlled study. Dig Dis Sci 2007; 52: 3259-65.
53. Minguez B, Garcia-Pagan JC, Bosch J, et al. Noncirrhotic portal vein thrombosis exhibits neuropsychological and MR changes consistent with minimal hepatic encephalopathy. Hepatology 2006; 43: 707-14.
54. Arria AM, Tarter RE, Starzl TE, Van Thiel DH. Improvement in cognitive functioning of alcoholics following orthotopic liver transplantation. Alcohol Clin Exp Res 1991; 15: 956-62.
55. Schomerus H, Hamster W. Neuropsychological aspects of portal-systemic encephalopathy. Metab Brain Dis 1998; 13: 361-77.
56. Kugler CF, Petter J, Taghavy A, et al. Dynamics of cognitive brain dysfunction in patients with cirrhotic liver disease: An event-related P300 potential perspective. Electroencephalogr Clin Neurophysiol 1994; 91: 33-41.
57. Nomenclature AAHCoNL. The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes. Arthritis Rheum 1999; 42: 559-608.
58. Nuechterlein KH, Green MF, Kern RS, et al. The MATRICS Consensus Cognitive Battery, part 1: Test selection, reliability, and validity. Am J Psychiatry 2008; 165: 203-13.
59. Schomerus H, Weissenborn K, Hamster W, Ruckert N, Hecker H. PSE-Syndrom-Test. Frankfurt: Swets & Zeitlinger B.V., 1999.
60. Randolph C. The Repeatable Battery for the Assessment of Neuropsychological Status (RBANS). San Antonio: The Psychological Corporation, 1998.
61. Gold JM, Goldberg R, McNary S, Dixon L, Lehman A. Cognitive correlates of job tenure among patients with severe mental illness. Am J Psychiatry 2002; 159: 1395-402.
62. Senzolo M, Amodio P, D'Aloiso MC, et al. Neuropsychological and neurophysiological evaluation in cirrhotic patients with minimal hepatic encephalopathy undergoing liver transplantation. Transplant Proc 2005; 37: 1104-7.
63. Weissenborn K, Ahl B, Fischer-Wasels D, et al. Correlations between magnetic resonance spectroscopy alterations and cerebral ammonia and glucose metabolism in cirrhotic patients with and without hepatic encephalopathy. Gut 2007; 56: 1736-42.
64. Lockwood AH, Weissenborn K, Bokemeyer M, Tietge U, Burchert W. Correlations between cerebral glucose metabolism and neuropsychological test performance in nonalcoholic cirrhotics. Metab Brain Dis 2002; 17: 29-40.
65. Ahl B, Weissenborn K, van den Hoff J, et al. Regional differences in cerebral blood flow and cerebral ammonia metabolism in patients with cirrhosis. Hepatology 2004; 40: 73-9.
66. Amodio P, Campagna F, Olianas S, et al. Detection of minimal hepatic encephalopathy: Normalization and optimization of the Psychometric Hepatic Encephalopathy Score. A neuropsychological and quantified EEG study. J Hepatol 2008; 49: 346-53.
67. Mooney S, Hasssanein TI, Hilsabeck RC, et al. Utility of the repeatable battery for the assessment of neuropsychological status (RBANS) in patients with end-stage liver disease awaiting liver transplant. Arch Clin Neuropsychol 2007; 22: 175-86.
68. Larson E, Kirschner K, Bode R, Heinemann A, Goodman R. Construct and predictive validity of the repeatable battery for the assessment of neuropsychological status in the evaluation of stroke patients. J Clin Exp Neuropsychol 2005; 27: 16-32.
69. Goldberg R, Lucksted A, McNary S, et al. Correlates of long-term unemployment among inner-city adults with serious and persistent mental illness. Psychiatr Serv 2001; 52: 101-3.
70. Freilich BM, Hyer LA. Relation of the repeatable battery for assessment of neuropsychological status to measures of daily functioning in dementia. Psychol Rep 2007; 101: 119-29.